Prescribing Hope: The Podcast
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
Global Vitiligo Foundation President Seemal Desai, MD, Associate Professor of Clinical Dermatology at the University of Texas-Southwestern in Dallas, TX, and Pearl E. Grimes, MD, Director of the Vitiligo and Pigmentation Institute of Southern California in Los Angeles, CA, have devoted much of their careers to treating vitiligo. In this episode of Prescribing Hope: The Podcast, they discuss the revolution and evolution of vitiligo treatment, spurred by the approval of topical ruxolitinib (Opzelura, Incyte) and bolstered by a robust pipeline.
adbl_web_anon_alc_button_suppression_c
No reviews yet